2015
DOI: 10.1016/j.ejmech.2015.06.016
|View full text |Cite
|
Sign up to set email alerts
|

Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii

Abstract: The treatment of some infectious diseases can currently be very challenging since the spread of multi-, extended- or pan-resistant bacteria has considerably increased over time. On the other hand, the number of new antibiotics approved by the FDA has decreased drastically over the last 30 years. The main objective of this study was to investigate the activity of wasp peptides, specifically mastoparan and some of its derivatives against extended-resistant Acinetobacter baumannii. We optimized the stability of m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
21
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(25 citation statements)
references
References 33 publications
3
21
0
Order By: Relevance
“…The components of bee venom have been extensively studied for their biological, toxicological, and pharmacological actions. The venom peptides mastoparan and melittin exhibit antimicrobial activity towards a broad range of bacteria 21,22 . Melittin is a representative bee venom peptide with 26 amino acids and is known to have excellent antimicrobial activity but high cytotoxicity in mammalian cells 23 .…”
Section: Discussionmentioning
confidence: 99%
“…The components of bee venom have been extensively studied for their biological, toxicological, and pharmacological actions. The venom peptides mastoparan and melittin exhibit antimicrobial activity towards a broad range of bacteria 21,22 . Melittin is a representative bee venom peptide with 26 amino acids and is known to have excellent antimicrobial activity but high cytotoxicity in mammalian cells 23 .…”
Section: Discussionmentioning
confidence: 99%
“…AMPs derived from wasp and scorpion venom have been widely tested against different microorganisms and have a microbicidal function on bacteria and fungi, besides having antiviral action [33]. Although the bactericidal activity of Agelaia-MPI against Gram-negative bacteria was not tested before, we believe that it could involve the interaction of the peptide with negatively-charged molecules on the surface of bacteria that would cause disruption of bacterial membranes [31,55]. Because AMPs acts on the lipid portion of cellular membranes, it is believed that they could avoid the development of resistance mechanisms such as those commonly induced by antibiotics, i.e., A. baumannii bacterial resistance mechanisms to conventional antibiotics comprises multidrug efflux pumps, aminoglycoside-modifying enzymes, selective membrane permeability, alteration of target sites, and hydrolytic enzymes like carbapenemase [56,57,58].…”
Section: Discussionmentioning
confidence: 99%
“…In several organisms, antimicrobial peptides, as components of the innate immune system, represent the first barrier against microbial infections and can interact with different targets such as membranes, cell wall, nucleic acid or cytosolic proteins . The mechanism of action of antimicrobial peptides is primarily related to the global positive charge of most of them, leading to interaction with anionic microorganism membranes, leading to the formation of pores, or acting as detergents, among other membrane level mechanisms of action …”
Section: Discussionmentioning
confidence: 99%
“…With regard to the antimicrobial peptides used in this study, it is known that CMO interacts with bacterial lipid bilayers resulting in drastic changes in membrane morphology, Mastoparan analogues (with an extra positive charge at the C‐terminal) cause disruption of bacterial membrane and Pa ‐MAP antimicrobial activity can be attributed mostly to its hydrophobic interactions . CMO has demonstrated antimicrobial activity against S. aureus and K. pneumoniae , with mastoparan analogues working against Acinetobacter baumannii and Pa ‐MAP against S. aureus and E. coli…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation